Skip to content
Stop using now Drug recall · FDA · Published March 21, 2025

Haloperidol Decanoate Injection Recall: Bacterial Contamination Risk

Somerset Therapeutics recalls Haloperidol Decanoate 50mg/mL vials due to potential bacterial contamination. This injection risks infection if used. Contact the manufacturer for details.

🇺🇸 FDA recall #D-0356-2025DrugSomerset Therapeutics ›
Take action

Contact the company

Recalling firmSomerset Therapeutics Private Limited54/1 Budihal Village · Bengaluru, India
✎ GovInfoNow plain-language explainer

Somerset Therapeutics is recalling Haloperidol Decanoate Injection vials because they may contain bacteria. Using these vials could lead to infections, so affected users should stop using them immediately. Read more at govinfonow.com/recall/32174-haloperidol-decanoate-injection-recall-bacterial-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32174-haloperidol-decanoate-injection-recall-bacterial-contamination-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0356-2025

Cite this page

“Haloperidol Decanoate Injection Recall: Bacterial Contamination Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32174-haloperidol-decanoate-injection-recall-bacterial-contamination-risk. Based on FDA recall #D-0356-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0356-2025%22&limit=1).

Somerset Therapeutics Private Limited voluntarily recalled Haloperidol Decanoate Injection 50mg/mL on March 21, 2025, according to the FDA. The recall addresses a lack of assurance of sterility due to bacterial contamination in media fills.

How to tell if you have it

  • Brand: Somerset Therapeutics
  • Product: Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial
  • NDC: 68001-580-41
  • Lot code: A240467B
  • Expiration date: 07/2026
  • Quantity: 4956 vials

The hazard

The recall involves a lack of assurance of sterility caused by media fill with bacterial contamination. The FDA classified the recall as Class II.

Context

GovInfoNow's records show Somerset Therapeutics previously recalled Cisatracurium Besylate Injection on November 26, 2025, due to subpotent product risk. Other recent recalls of similar products include Victory Medical Center Pharmacy Glutathione Vials Recall (July 1, 2026) and ProRx Semaglutide Injection Recall (October 15, 2025).

How to tell if you have this one

Check for vials labeled 'Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only' with NDC code 68001-580-41. The vials were manufactured by Somerset Therapeutics Limited in India and expire by July 2026.

  • Brand
    Somerset Therapeutics
  • Category
    Drug
FDA recall event · 5 products

All 5 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S. Nationwide
Recall numberProduct, codes & lotsQuantityNDC
D-0354-2025Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton); NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026; A240342, A240347, A240385, A240391, exp. date 06/2026; NDC 70069-101-05; A240326, exp. date 05/2026506,080 vials70069-101-25, 70069-101-10, 70069-101-05
D-0355-2025Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-381-01 (individual carton) and NDC 70069-381-10 (10x1 mL carton); NDC 70069-381-01; A240467A, exp. date 07/2026; NDC 70069-381-10; A240467C, exp. date 07/2026997 vials70069-030-05, 70069-030-03, 70069-031-01, 70069-031-05, 70069-381-01, 70069-381-10, 70069-382-01, 70069-382-05, 70069-383-05, 70069-383-10, 70069-383-01, 70069-384-01, 70069-384-05
D-0356-2025Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41; A240467B, exp. date 07/20264956 vials68001-579-59, 68001-579-48, 68001-580-41, 68001-581-41, 68001-581-48, 68001-581-82, 68001-578-59, 68001-578-48, 68001-582-41
D-0357-2025Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons); NDC 68001-581-41; A240482A, exp. date 08/2026; NDC 68001-581-48; A240482B, exp. date 08/202623,960 vials68001-579-59, 68001-579-48, 68001-580-41, 68001-581-41, 68001-581-48, 68001-581-82, 68001-578-59, 68001-578-48, 68001-582-41
D-0358-2025Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10; A240482D, exp. date 08/2026240 vials70069-030-05, 70069-030-03, 70069-031-01, 70069-031-05, 70069-381-01, 70069-381-10, 70069-382-01, 70069-382-05, 70069-383-05, 70069-383-10, 70069-383-01, 70069-384-01, 70069-384-05
Based on the official FDA remedy

What to do — step by step

  1. Stop Using It Now

    Immediately discard the vial if you have it, as it may contain bacteria that could cause infection.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: Mar 21, 202512. FDA classified it Class II: Apr 8, 202523. Published in FDA’s Enforcement Report: Apr 16, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0356-2025 (March 21, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0356-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA